Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q45722385)
Watch
English
Getting oncolytic virus therapies off the ground
scientific article published in July 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
title
Getting oncolytic virus therapies off the ground
(English)
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
main subject
oncolytic virus
1 reference
based on heuristic
inferred from title
author
John C Bell
series ordinal
1
object named as
John C Bell
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
David F Stojdl
series ordinal
3
object named as
David Stojdl
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
Brian Dennis Lichty
series ordinal
2
object named as
Brian Lichty
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
publication date
1 July 2003
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
published in
Cancer Cell
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
volume
4
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
page(s)
7-11
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
issue
1
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
cites work
Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting of adenoviral vectors for gene therapy of prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multigene expression from a replicating adenovirus using native viral promoters
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An oncolytic measles virus engineered to enter cells through the CD20 antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intergeneric poliovirus recombinants for the treatment of malignant glioma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel gene therapy approach for nasopharyngeal carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tissue-specific transcriptional targeting of a replication-competent retroviral vector
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor-specific transcriptional targeting of suicide gene therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficiency of measles virus entry and dissemination through different receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic herpes simplex virus vectors for cancer virotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The complement response against an oncolytic virus is species-specific in its activation pathways
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900170-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1535-6108(03)00170-3
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
PubMed ID
12892708
1 reference
stated in
Q5412157
PubMed ID
12892708
retrieved
15 December 2017
ResearchGate publication ID
10633809
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
